E-prescribing Market By Product (solutions And Services), End User (hospitals, Pharmaceuticals And Office-based Physicians) And Delivery Mode (on-premise And Web And Cloud-based)- Global Industry Analysis And Forecast To 2023

Published On : July 2018 Pages : 190 Category: Telecom & Wireless Report Code : IC071097

Industry Outlook and Trend Analysis

The E-prescribing Market was worth USD 0.32 billion in 2014 and is expected to reach approximately USD 1.74 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 20.71% during the forecast period. E-Prescribing helps in enhancing the quality of care, accuracy and accentuation on the safety of patients. Medical mistakes including medication error have raised genuine concern about patient's security. These mistakes essentially happen because of hand-writing illegibility, incorrect dosage, hand-composing indecipherability, and others. Government bodies of different nations are assisting the implementation of e-prescribing and electronic medicinal records and framing a national wellbeing data framework. E-prescribing has fundamentally diminished medicine and prescription blunders and has brought about less call-back to doctors from the drug specialists for elucidation. Additionally, electronic transfer of medicines from prescribers to drug specialists has to a great extent helped in streamlining the clinical work process.

Drivers and Restraints

E-prescribing systems are broadly used for preparing complete lists of medications. Besides, they additionally help information security checks and extraction of complete data of patient history and model. The worldwide E-prescribing market is picking up footing because of expanding applications in medicinal services and considerable help from governments over the globe. Developing requirement for enhanced quality of healthcare and limited errors is another key driver anticipated that would fuel the market development amid the gauge time frame. A considerable number of medical and healthcare centers in developing economies are progressively implementing electronic health record systems (EHRs), which will additionally reinforce the interest for E-prescribing. Nonetheless, considerable adoption of E-prescribing systems is observing impediment because of higher initial expenses and dangers associated with security and protection of patients' information.

Market Segmentation

The E-prescribing Market is segmented on the basis of Product into Solutions and Services. By End User the market is segmented into Hospitals, Pharmaceuticals, Office-based Physicians and based on Delivery Mode the market is segmented into On-premise, Web and Cloud-based.

Regional Outlook and Trend Analysis

Europe holds the biggest share of the market, inferable from expanding eHealth extends over the district. Increasing rate of adoption of the European Patient Smart Open Services (epSOS) is foreseen to reinforce the market in Europe, combined with the Schleswig-Holstein Health Initiative. North America will is anticipated to account for the quickest developing regional market, credited to higher adoption of electronic prescribing systems to help the  advanced healthcare infrastructure.

Competitive Insights

The leading players in the market are Cerner, Surescripts, Epic Systems, Practice Fusion, DrFirst.com Inc, Henry Schein and Quality Systems. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The E-prescribing Market is segmented based on regions as follows-

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         E-prescribing Market, By Product, Estimates and Forecast, 2014-2023($Billion)

o    Solutions

o    Services

·         E-prescribing Market, By Delivery Mode, Estimates and Forecast, 2014-2023($Billion)

o    On-premise

o    Web and Cloud-based

·         E-prescribing Market, By End User, Estimates and Forecast, 2014-2023($Billion)

o    Hospitals

o    Pharmaceuticals

o    Office-based Physicians

·         E-prescribing Market, By Region, Estimates and Forecast, 2014-2023($Billion)

o    North America

§  North America E-prescribing Market, By Country

o    U.S. E-prescribing Market

o    Canada E-prescribing Market

o    Mexico E-prescribing Market

o    Europe

§  Europe E-prescribing Market, By Country

o    Germany E-prescribing Market

o    UK E-prescribing Market

o    France E-prescribing Market

o    Russia E-prescribing Market

o    Italy E-prescribing Market

o    Rest of Europe E-prescribing Market

o    Asia-Pacific

§  Asia-Pacific E-prescribing Market, By Country

o    China E-prescribing Market

o    Japan E-prescribing Market

o    South Korea E-prescribing Market

o    India E-prescribing Market

o    Southeast Asia E-prescribing Market

o    Rest of Asia-Pacific E-prescribing Market

o    South America

§  South America E-prescribing Market

o    Brazil E-prescribing Market

o    Argentina E-prescribing Market

o    Columbia E-prescribing Market

o    South Africa E-prescribing Market

o    Rest of South America E-prescribing Market

o    Middle East and Africa

§  Middle East and Africa E-prescribing Market

o    Saudi Arabia E-prescribing Market

o    UAE E-prescribing Market

o    Egypt E-prescribing Market

o    Nigeria E-prescribing Market

o    South Africa E-prescribing Market

o    Rest of MEA E-prescribing Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2014-2023)

4.1.2.  Canada Market States and Outlook (2014-2023)

4.1.3.  Mexico Market States and Outlook (2014-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2014-2023)

4.2.2.  France Market States and Outlook (2014-2023)

4.2.3.  UK Market States and Outlook (2014-2023)

4.2.4.  Russia Market States and Outlook (2014-2023)

4.2.5.  Italy Market States and Outlook (2014-2023)

4.2.6.  Rest of Europe Market States and Outlook (2014-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2014-2023)

4.3.2.  Japan Market States and Outlook (2014-2023)

4.3.3.  Korea Market States and Outlook (2014-2023)

4.3.4.  India Market States and Outlook (2014-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2014-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2014-2023)

4.4.2.  Argentina Market States and Outlook (2014-2023)

4.4.3.  Columbia Market States and Outlook (2014-2023)

4.4.4.  Rest of South America Market States and Outlook (2014-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2014-2023)

4.5.2.  UAE Market States and Outlook (2014-2023)

4.5.3.  Egypt Market States and Outlook (2014-2023)

4.5.4.  Nigeria Market States and Outlook (2014-2023)

4.5.5.  South Africa Market States and Outlook (2014-2023)

4.5.6.  Rest of MEA Market States and Outlook (2014-2023)

5.       E-prescribing Market, By Product

5.1.       Introduction

5.2.       Global E-prescribing Revenue and Market Share by Product (2014-2018)

5.2.1.  Global E-prescribing Revenue and Revenue Share by Product (2014-2018)

5.3.       Solutions

5.3.1.  Global Solutions Revenue and Growth Rate (2014-2018)

5.4.       Services

5.4.1.  Global Services Revenue and Growth Rate (2014-2018)

6.       E-prescribing Market, By End User

6.1.       Introduction

6.2.       Global E-prescribing Revenue and Market Share by End User (2014-2018)

6.2.1.  Global E-prescribing Revenue and Revenue Share by End User (2014-2018)

6.3.       Hospitals

6.3.1.  Global Hospitals Revenue and Growth Rate (2014-2018)

6.4.       Pharmaceuticals

6.4.1.  Global Pharmaceuticals Revenue and Growth Rate (2014-2018)

6.5.       Office-based Physicians

6.5.1.  Global Office-based Physicians Revenue and Growth Rate (2014-2018)

7.       E-prescribing Market, By Delivery Mode

7.1.       Introduction

7.2.       Global E-prescribing Revenue and Market Share by Delivery Mode (2014-2018)

7.2.1.  Global E-prescribing Revenue and Revenue Share by Delivery Mode (2014-2018)

7.3.       On-premise

7.3.1.  Global On-premise Revenue and Growth Rate (2014-2018)

7.4.       Web and Cloud-based

7.4.1.  Global Web and Cloud-based Revenue and Growth Rate (2014-2018)

8.       E-prescribing Market, By Region

8.1.       Introduction

8.2.       Global E-prescribing Revenue and Market Share by Regions

8.2.1.  Global E-prescribing Revenue by Regions (2014-2018)

8.3.       North America E-prescribing by Countries

8.3.1.  North America E-prescribing Revenue and Growth Rate (2014-2018)

8.3.2.  North America E-prescribing Revenue by Countries (2014-2018)

8.3.3.  North America E-prescribing Revenue (Million USD) by Countries (2014-2018)

8.3.4.  U.S.

8.3.4.1.    United States E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5.  Canada

8.3.5.1.    Canada E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.6.  Mexico

8.3.6.1.    Mexico E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.       Europe E-prescribing by Countries

8.4.1.  Europe E-prescribing Revenue and Growth Rate (2014-2018)

8.4.2.  Europe E-prescribing Revenue by Countries (2014-2018)

8.4.3.  Europe E-prescribing Revenue (Million USD) by Countries (2014-2018)

8.4.4.  Germany

8.4.4.1.    Germany E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5.  UK

8.4.5.1.    UK E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  France

8.4.6.1.    France E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  Russia

8.4.7.1.    Russia E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Italy

8.4.8.1.    Italy E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.9.  Rest of Europe

8.4.9.1.    Rest of Europe E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.       Asia-Pacific

8.5.1.  Asia-Pacific E-prescribing Revenue and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific E-prescribing Revenue by Countries (2014-2018)

8.5.3.  Asia-Pacific E-prescribing Revenue (Million USD) by Countries (2014-2018)

8.5.4.  China

8.5.4.1.    China E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.  Japan

8.5.5.1.    Japan E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.2.     

8.5.6.  Korea

8.5.6.1.    Korea E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  India

8.5.7.1.    India E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  Southeast Asia

8.5.8.1.    Southeast Asia E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.9.  Rest of Asia-Pacific

8.5.9.1.    Rest of Asia-Pacific E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.       South America

8.6.1.  South America E-prescribing Revenue and Growth Rate (2014-2018)

8.6.2.  South America E-prescribing Revenue by Countries (2014-2018)

8.6.3.  South America E-prescribing Revenue (Million USD) by Countries (2014-2018)

8.6.4.  Brazil

8.6.4.1.    Brazil E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5.  Argentina

8.6.5.1.    Argentina E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Columbia

8.6.6.1.    Columbia E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.7.  Rest of South America

8.6.7.1.    Rest of South America E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.       Middle East and Africa

8.7.1.  Middle East and Africa E-prescribing Revenue and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa E-prescribing Revenue by Countries (2014-2018)

8.7.3.  Middle East and Africa E-prescribing Revenue (Million USD) by Countries (2014-2018)

8.7.4.  Saudi Arabia

8.7.4.1.    Saudi Arabia E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5.  United Arab Emirates

8.7.5.1.    United Arab Emirates E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  Egypt

8.7.6.1.    Egypt E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  Nigeria

8.7.7.1.    Nigeria E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  South Africa

8.7.8.1.    South Africa E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.    Rest of Middle East and Africa E-prescribing Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.       Epic Systems Corporation

9.1.1.  Business Overview

9.1.2.  Product Portfolio

9.1.3.  Strategic Developments

9.1.4.  Revenue and Market Share

9.2.       Cerner Corporation

9.2.1.  Business Overview

9.2.2.  Product Portfolio

9.2.3.  Strategic Developments

9.2.4.  Revenue and Market Share

9.3.       Quality Systems, Inc.

9.3.1.  Business Overview

9.3.2.  Product Portfolio

9.3.3.  Strategic Developments

9.3.4.  Revenue and Market Share

9.4.       DrFirst.com, Inc.

9.4.1.  Business Overview

9.4.2.  Product Portfolio

9.4.3.  Strategic Developments

9.4.4.  Revenue and Market Share

9.5.       Henry Schein, Inc.

9.5.1.  Business Overview

9.5.2.  Product Portfolio

9.5.3.  Strategic Developments

9.5.4.  Revenue and Market Share

9.6.       Surescripts, LLC

9.6.1.  Business Overview

9.6.2.  Product Portfolio

9.6.3.  Strategic Developments

9.6.4.  Revenue and Market Share

9.7.       Practice Fusion, Inc.

9.7.1.  Business Overview

9.7.2.  Product Portfolio

9.7.3.  Strategic Developments

9.7.4.  Revenue and Market Share

10.   Global E-prescribing Market Competition, by Manufacturer

10.1.    Global E-prescribing Revenue and Market Share by Manufacturer (2016-2017)

10.2.    Global E-prescribing Price by Region (2016-2017)

10.3.    Top 5 E-prescribing Manufacturer Market Share

10.4.    Market Competition Trend

11.   E-prescribing Market Forecast (2018-2023)

11.1.    Global E-prescribing Revenue (Millions USD) and Growth Rate (2018-2023)

11.2.    E-prescribing Market Forecast by Regions (2018-2023)

11.2.1.      North America E-prescribing Market Forecast (2018-2023)

11.2.1.1. United States E-prescribing Market Forecast (2018-2023)

11.2.1.2. Canada E-prescribing Market Forecast (2018-2023)

11.2.1.3. Mexico E-prescribing Market Forecast (2018-2023)

11.2.2.      Europe E-prescribing Market Forecast (2018-2023)

11.2.2.1. Germany E-prescribing Market Forecast (2018-2023)

11.2.2.2. United Kingdom E-prescribing Market Forecast (2018-2023)

11.2.2.3. France E-prescribing Market Forecast (2018-2023)

11.2.2.4. Russia E-prescribing Market Forecast (2018-2023)

11.2.2.5. Italy E-prescribing Market Forecast (2018-2023)

11.2.2.6. Rest of the Europe E-prescribing Market Forecast (2018-2023)

11.2.3.      Asia-Pacific E-prescribing Market Forecast (2018-2023)

11.2.3.1. China E-prescribing Market Forecast (2018-2023)

11.2.3.2. Japan E-prescribing Market Forecast (2018-2023)

11.2.3.3. Korea E-prescribing Market Forecast (2018-2023)

11.2.3.4. India E-prescribing Market Forecast (2018-2023)

11.2.3.5. Southeast Asia E-prescribing Market Forecast (2018-2023)

11.2.3.6. Rest of Asia-Pacific E-prescribing Market Forecast (2018-2023)

11.2.4.      South America E-prescribing Market Forecast (2018-2023)

11.2.4.1. Brazil E-prescribing Market Forecast (2018-2023)

11.2.4.2. Argentina E-prescribing Market Forecast (2018-2023)

11.2.4.3. Columbia E-prescribing Market Forecast (2018-2023)

11.2.4.4. Rest of South America E-prescribing Market Forecast (2018-2023)

11.2.5.      Middle East and Africa E-prescribing Market Forecast (2018-2023)

11.2.5.1. Saudi Arabia E-prescribing Market Forecast (2018-2023)

11.2.5.2. UAE E-prescribing Market Forecast (2018-2023)

11.2.5.3. Egypt E-prescribing Market Forecast (2018-2023)

11.2.5.4. Nigeria E-prescribing Market Forecast (2018-2023)

11.2.5.5. South Africa E-prescribing Market Forecast (2018-2023)

11.2.5.6. Rest of MEA E-prescribing Market Forecast (2018-2023)

11.3.    E-prescribing Market Forecast by Product (2018-2023)

11.3.1.      Global E-prescribing Revenue Forecast by Product (2018-2023)

11.3.2.      Global E-prescribing Revenue Market Share Forecast by Product (2018-2023)

11.4.    E-prescribing Market Forecast by End User (2018-2023)

11.4.1.      Global E-prescribing Revenue Forecast by End User (2018-2023)

11.4.2.      Global E-prescribing Revenue Market Share Forecast by End User (2018-2023)

11.5.    E-prescribing Market Forecast by Delivery Mode (2018-2023)

11.5.1.      Global E-prescribing Revenue Forecast by Delivery Mode (2018-2023)

11.5.2.      Global E-prescribing Revenue Market Share Forecast by Delivery Mode (2018-2023)


List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of E-prescribing Market.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*